Wanbangde Pharmaceutical Holding Group Co., Ltd. (SHE:002082)

SHE:002082 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 2, 2026	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Market Capitalization	9,542	3,933	3,915	5,409	9,082	8,470
Market Cap Growth	151.21%	0.47%	-27.62%	-40.45%	7.23%	276.58%
Enterprise Value	10,466	4,899	4,825	5,870	9,910	10,091
Last Close Price	15.60	6.43	6.28	8.51	14.27	13.02
PE Ratio	671.87	70.94	79.56	58.00	54.55	29.73
Forward PE	-	6.44	6.44	6.44	6.44	6.44
PS Ratio	6.88	2.73	2.54	3.03	4.70	0.62
PB Ratio	3.45	1.43	1.42	1.92	3.31	2.96
P/TBV Ratio	4.56	1.89	1.85	2.54	4.53	4.43
P/FCF Ratio	-	170.18	-	-	-	-
P/OCF Ratio	463.89	32.72	-	-	411.24	56.09
EV/Sales Ratio	7.55	3.39	3.13	3.29	5.13	0.74
EV/EBITDA Ratio	91.56	28.75	29.42	17.40	32.48	18.51
EV/EBIT Ratio	-	65.52	68.74	25.24	47.04	23.03
EV/FCF Ratio	-40.53	211.95	-	-	-	-
Debt / Equity Ratio	0.33	0.37	0.35	0.31	0.31	0.66
Debt / EBITDA Ratio	8.01	5.93	5.84	2.55	2.76	3.44
Debt / FCF Ratio	-	44.49	-	-	-	-
Asset Turnover	0.32	0.34	0.36	0.42	0.39	2.54
Inventory Turnover	3.28	3.61	3.41	3.13	1.80	15.14
Quick Ratio	0.92	0.93	1.09	1.57	1.63	1.03
Current Ratio	1.47	1.37	1.45	1.94	1.92	1.65
Return on Equity (ROE)	0.37%	1.64%	0.94%	2.65%	5.75%	10.27%
Return on Assets (ROA)	0.20%	1.08%	1.03%	3.38%	2.63%	5.08%
Return on Invested Capital (ROIC)	0.17%	1.61%	1.84%	5.81%	2.75%	9.50%
Return on Capital Employed (ROCE)	0.40%	2.50%	2.40%	7.50%	6.80%	11.50%
Earnings Yield	0.15%	1.41%	1.26%	1.72%	1.83%	3.36%
FCF Yield	-2.71%	0.59%	-5.15%	-7.52%	-2.90%	-4.82%
Dividend Yield	-	-	1.27%	1.41%	-	1.54%
Payout Ratio	259.40%	163.85%	247.98%	47.08%	115.10%	59.93%
Buyback Yield / Dilution	21.16%	-0.15%	1.06%	-0.82%	-1.73%	-21.45%
Total Shareholder Return	21.16%	-0.15%	2.34%	0.59%	-1.73%	-19.91%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.